André Bélanger

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Efficacy of essential oil of Ocimum basilicum L. and O. gratissimum L. applied as an insecticidal fumigant and powder to control Callosobruchus maculatus (Fab.) [Coleoptera: Bruchidae]

Sékou Moussa Kéita, Charles Vincent, Jean‐Pierre Schmit et al. · Journal of Stored Products Research · 2001 · 310 citations

Life Sciences, Entomology, Plant Sciences +17

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy

Yves Lacourciére, André Bélanger, Chantal Godin et al. · Kidney International · 2000 · 229 citations · Full text

Medicine, Nephrology, Pharmacotherapy +13

Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 1 Diabetes

Teresa Quattrin, André Bélanger, Nancy J.V. Bohannon et al. · Diabetes Care · 2004 · 226 citations · Full text

Pharmacy, Internal Medicine, Pharmacology +10